{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T07:04:13Z","timestamp":1782025453489,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T00:00:00Z","timestamp":1458691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["19790.01"],"award-info":[{"award-number":["19790.01"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PBSKP3_145774"],"award-info":[{"award-number":["PBSKP3_145774"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000783","name":"Research Executive Agency","doi-asserted-by":"publisher","award":["PIOF-GA-2012-332311"],"award-info":[{"award-number":["PIOF-GA-2012-332311"]}],"id":[{"id":"10.13039\/501100000783","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"UK Department of Health","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development","doi-asserted-by":"publisher","award":["MR\/K012126\/1"],"award-info":[{"award-number":["MR\/K012126\/1"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12916-016-0589-3","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T16:19:25Z","timestamp":1457713165000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study"],"prefix":"10.1186","volume":"14","author":[{"given":"Sabine M.","family":"Hermans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison D.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violet","family":"Chihota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Vynnycky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin J.","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,23]]},"reference":[{"key":"589_CR1","unstructured":"World Health Organization. Report on global tuberculosis control. 2015. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/191102\/1\/9789241565059_eng.pdf?ua=1\n                    \n                  . Accessed 25 November 2015."},{"key":"589_CR2","unstructured":"World Health Organization. Interim policy on collaborative TB\/HIV activities. 2004. \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/78705\/1\/WHO_HTM_TB_2004.330_eng.pdf\n                    \n                  . Accessed 17 March 2009."},{"key":"589_CR3","first-page":"CD000171","volume":"1","author":"C Akolo","year":"2010","unstructured":"Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;1:CD000171.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9944","key":"589_CR4","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0140-6736(14)60162-8","volume":"384","author":"M Rangaka","year":"2014","unstructured":"Rangaka M, Wilkinson RJ, Boulle A, Glynn JR, Fielding K, Van Cutsem G, et al. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind placebo-controlled trial. Lancet. 2014;384(9944):682\u201390.","journal-title":"Lancet"},{"issue":"3","key":"589_CR5","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5588\/ijtld.12.0298","volume":"17","author":"BJ Kirenga","year":"2013","unstructured":"Kirenga BJ, Worodria W, Massinga-Loembe M, Nalwoga T, Manabe YC, Kestens L, et al. Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda. Int J Tuberc Lung Dis. 2013;17(3):336\u201341.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"589_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMoa1214289","volume":"370","author":"GJ Churchyard","year":"2014","unstructured":"Churchyard GJ, Fielding KL, Lewis JJ, Coetzee L, Corbett EL, Godfrey-Faussett P, et al. A trial of mass isoniazid preventive therapy for tuberculosis control. N Engl J Med. 2014;370(4):301\u201310.","journal-title":"N Engl J Med"},{"issue":"9777","key":"589_CR7","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","volume":"377","author":"T Samandari","year":"2011","unstructured":"Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9777):1588\u201398.","journal-title":"Lancet"},{"issue":"1","key":"589_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1005136","volume":"365","author":"NA Martinson","year":"2011","unstructured":"Martinson NA, Barnes GL, Moulton LH, Msandiwa R, Hausler H, Ram M, et al. New regimens to prevent tuberculosis in adults with HIV infection. N Engl J Med. 2011;365(1):11\u201320.","journal-title":"N Engl J Med"},{"issue":"3","key":"589_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/QAD.0000000000000535","volume":"29","author":"T Samandari","year":"2015","unstructured":"Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Mosimaneotsile B, et al. Tuberculosis incidence after 36\u00a0months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis. AIDS. 2015;29(3):351\u20139.","journal-title":"AIDS"},{"issue":"10","key":"589_CR10","first-page":"1149","volume":"134","author":"DA Enarson","year":"1986","unstructured":"Enarson DA, Grzybowski S. Incidence of active tuberculosis in the native population of Canada. Can Med Assoc J. 1986;134(10):1149\u201352.","journal-title":"Can Med Assoc J"},{"issue":"5","key":"589_CR11","first-page":"827","volume":"119","author":"GW Comstock","year":"1979","unstructured":"Comstock GW, Baum C, Snider Jr DE. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis. 1979;119(5):827\u201330.","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"589_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cct.2010.12.008","volume":"32","author":"KL Fielding","year":"2011","unstructured":"Fielding KL, Grant AD, Hayes RJ, Chaisson RE, Corbett EL, Churchyard GJ. Thibela TB: design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa. Contemp Clin Trials. 2011;32(3):382\u201392.","journal-title":"Contemp Clin Trials"},{"issue":"Suppl 5","key":"589_CR13","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/01.aids.0000391020.10661.eb","volume":"24","author":"AD Grant","year":"2010","unstructured":"Grant AD, Coetzee L, Fielding KL, Lewis JJ, Ntshele S, Luttig MM, et al. \u2018Team up against TB\u2019: promoting involvement in Thibela TB, a trial of community-wide tuberculosis preventive therapy. AIDS. 2010;24 Suppl 5:S37\u201344.","journal-title":"AIDS"},{"issue":"1","key":"589_CR14","first-page":"39","volume":"13","author":"Y Hanifa","year":"2009","unstructured":"Hanifa Y, Grant AD, Lewis J, Corbett EL, Fielding K, Churchyard G. Prevalence of latent tuberculosis infection among gold miners in South Africa. Int J Tuberc Lung Dis. 2009;13(1):39\u201346.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"589_CR15","doi-asserted-by":"publisher","first-page":"e81376","DOI":"10.1371\/journal.pone.0081376","volume":"8","author":"JJ Lewis","year":"2013","unstructured":"Lewis JJ, Fielding KL, Grant AD, Chihota VN, Popane F, Luttig M, et al. Eligibility for isoniazid preventive therapy in South African gold mines. PLoS One. 2013;8(11):e81376.","journal-title":"PLoS One"},{"issue":"12","key":"589_CR16","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1164\/rccm.200806-846OC","volume":"180","author":"JJ Lewis","year":"2009","unstructured":"Lewis JJ, Charalambous S, Day JH, Fielding KL, Grant AD, Hayes RJ, et al. HIV infection does not affect active case finding of tuberculosis in South African gold miners. Am J Respir Crit Care Med. 2009;180(12):1271\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"589_CR17","first-page":"CD001363","volume":"2","author":"MJ Smieja","year":"2000","unstructured":"Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 2000;2:CD001363.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"589_CR18","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1164\/rccm.200409-1200OC","volume":"171","author":"S Verver","year":"2005","unstructured":"Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005;171(12):1430\u20135.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"589_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cid\/cis798","volume":"56","author":"T Lahey","year":"2013","unstructured":"Lahey T, Mackenzie T, Arbeit RD, Bakari M, Mtei L, Matee M, et al. Recurrent tuberculosis risk among HIV-infected adults in Tanzania with prior active tuberculosis. Clin Infect Dis. 2013;56(1):151\u20138.","journal-title":"Clin Infect Dis"},{"key":"589_CR20","doi-asserted-by":"publisher","DOI":"10.1201\/9781584888178","volume-title":"Cluster randomised trials. Interdisciplinary Statistics Series","author":"RJ Hayes","year":"2009","unstructured":"Hayes RJ, Moulton LH. Cluster randomised trials. Interdisciplinary Statistics Series. London: Chapman & Hall\/CRC Press; 2009."},{"issue":"12","key":"589_CR21","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1093\/cid\/ciu186","volume":"58","author":"FM Marx","year":"2014","unstructured":"Marx FM, Dunbar R, Enarson DA, Williams BG, Warren RM, van der Spuy GD, et al. The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study. Clin Infect Dis. 2014;58(12):1676\u201383.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"589_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/aje\/kwu320","volume":"181","author":"E Vynnycky","year":"2015","unstructured":"Vynnycky E, Sumner T, Fielding KL, Lewis JJ, Cox AP, Hayes RJ, et al. Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy. Am J Epidemiol. 2015;181(8):619\u201332.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"589_CR23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/oem.54.9.636","volume":"54","author":"I Kleinschmidt","year":"1997","unstructured":"Kleinschmidt I, Churchyard G. Variation in incidences of tuberculosis in subgroups of South African gold miners. Occup Environ Med. 1997;54(9):636\u201341.","journal-title":"Occup Environ Med"},{"issue":"2","key":"589_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00002030-200101260-00011","volume":"15","author":"MA Quigley","year":"2001","unstructured":"Quigley MA, Mwinga A, Hosp M, Lisse I, Fuchs D, Porter JDH, et al. Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults. AIDS. 2001;15(2):215\u201322.","journal-title":"AIDS"},{"issue":"16","key":"589_CR25","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1097\/00002030-200111090-00009","volume":"15","author":"JL Johnson","year":"2001","unstructured":"Johnson JL, Okwera A, Hom DL, Mayanja H, Mutuluuza Kityo C, Nsubuga P, et al. Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS. 2001;15(16):2137\u201347.","journal-title":"AIDS"},{"key":"589_CR26","unstructured":"Golub JE, Saraceni V, Cavalcante SC, Cohn S, Pacheco AG, Lau B, et al. Durability of isoniazid preventive therapy in HIV-positive patients in a medium burden TB setting. Atlanta, GA: 20th Conference on Retroviruses and Opportunistic Infections; 2012. Poster 190 LB."},{"issue":"4","key":"589_CR27","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1093\/cid\/ciu849","volume":"60","author":"JE Golub","year":"2015","unstructured":"Golub JE, Cohn S, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, et al. Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: The TB\/HIV in Rio (THRio) Study. Clin Infect Dis. 2015;60(4):639\u201345.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"589_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1183\/09031936.00070812","volume":"41","author":"GJ Fox","year":"2013","unstructured":"Fox GJ, Barry SE, Britton WJ, Marks GB. Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J. 2013;41(1):140\u201356.","journal-title":"Eur Respir J"},{"issue":"14","key":"589_CR29","doi-asserted-by":"publisher","first-page":"5325","DOI":"10.1073\/pnas.1317660111","volume":"111","author":"RM Houben","year":"2014","unstructured":"Houben RM, Sumner T, Grant AD, White RG. Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings. Proc Natl Acad Sci U S A. 2014;111(14):5325\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"589_CR30","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM199910143411602","volume":"341","author":"A van Rie","year":"1999","unstructured":"van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med. 1999;341(16):1174\u20139.","journal-title":"N Engl J Med"},{"issue":"8","key":"589_CR31","first-page":"942","volume":"12","author":"S Charalambous","year":"2008","unstructured":"Charalambous S, Grant AD, Moloi V, Warren R, Day JH, van Helden P, et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis. 2008;12(8):942\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"589_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/QAD.0b013e32832f51cf","volume":"24","author":"AC Crampin","year":"2010","unstructured":"Crampin AC, Mwaungulu JN, Mwaungulu FD, Mwafulirwa DT, Munthali K, Floyd S, et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi. AIDS. 2010;24(3):417\u201326.","journal-title":"AIDS"},{"issue":"6","key":"589_CR33","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/cid\/cir951","volume":"54","author":"JR Andrews","year":"2012","unstructured":"Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR. Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. Clin Infect Dis. 2012;54(6):784\u201391.","journal-title":"Clin Infect Dis"},{"key":"589_CR34","first-page":"CD007545","volume":"7","author":"SK Sharma","year":"2013","unstructured":"Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Cochrane Database Syst Rev. 2013;7:CD007545.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"589_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.7326\/M14-1019","volume":"161","author":"HR Stagg","year":"2014","unstructured":"Stagg HR, Zenner D, Harris RJ, Munoz L, Lipman MC, Abubakar I. Treatment of latent tuberculosis infection: a network meta-analysis. Ann Intern Med. 2014;161(6):419\u201328.","journal-title":"Ann Intern Med"},{"issue":"17","key":"589_CR36","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1097\/00002030-200012010-00016","volume":"14","author":"EL Corbett","year":"2000","unstructured":"Corbett EL, Churchyard GJ, Clayton TC, Williams BG, Mulder D, Hayes RJ, et al. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS. 2000;14(17):2759\u201368.","journal-title":"AIDS"},{"key":"589_CR37","volume-title":"South African National HIV Prevalence, Incidence and Behaviour Survey","author":"O Shisana","year":"2012","unstructured":"Shisana O, Rehle T, Simbayi L, Zuma K, Jooste S, Zungu N, et al. South African National HIV Prevalence, Incidence and Behaviour Survey. 2012. \n                    http:\/\/www.hsrc.ac.za\/en\/research-data\/view\/6871\n                    \n                  . Accessed 2 December 2013."},{"issue":"7","key":"589_CR38","doi-asserted-by":"publisher","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","volume":"9","author":"AB Suthar","year":"2012","unstructured":"Suthar AB, Lawn SD, del Amo J, Getahun H, Dye C, Sculier D, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med. 2012;9(7):e1001270.","journal-title":"PLoS Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-016-0589-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0589-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0589-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T17:06:31Z","timestamp":1589475991000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-016-0589-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,23]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s12916-016-0589-3","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,23]]},"assertion":[{"value":"14 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"45"}}